Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$6.88M Buy
85,621
+2,441
+3% +$187K 0.67% 19
2022
Q3
$5.54M Buy
83,180
+6,208
+8% +$459K 0.67% 17
2022
Q2
$5.85M Buy
76,972
+44,236
+135% +$3.36M 0.67% 16
2022
Q1
$2.6M Sell
32,736
-975
-3% -$70.9K 0.26% 104
2021
Q4
$2.47M Buy
33,711
+7,387
+28% +$498K 0.23% 124
2021
Q3
$1.81M Sell
26,324
-267
-1% -$20.3K 0.17% 185
2021
Q2
$2.24M Buy
26,591
+119
+0.4% +$9.92K 0.21% 146
2021
Q1
$2.15M Sell
26,472
-5,174
-16% -$442K 0.22% 138
2020
Q4
$2.75M Sell
31,646
-704
-2% -$60.9K 0.28% 74
2020
Q3
$2.9M Buy
32,350
+9,174
+40% +$885K 0.32% 65
2020
Q2
$2.41M Buy
23,176
+13,722
+145% +$1.32M 0.27% 81
2020
Q1
$1.11M Buy
9,454
+456
+5% +$34.4K 0.15% 187
2019
Q4
$786K Hold
8,998
0.08% 383
2019
Q3
$668K Buy
8,998
+1,589
+21% +$128K 0.07% 401
2019
Q2
$629K Buy
7,409
+4,950
+201% +$397K 0.07% 424
2019
Q1
$212K Hold
2,459
0.02% 546
2018
Q4
$156K Buy
+2,459
New +$160K 0.02% 533

Other funds holding INCY

Seeyond's INCY Position: Q4 2022 in Review

Seeyond increased its Incyte (INCY) stake by 2.9% in Q4 2022, buying an estimated $187K and bringing the position to 85,621 shares worth $6.88M. The position accounts for 0.67% of the portfolio, ranked #19.

Seeyond first reported a position in INCY in Q4 2018 and has held it in 17 quarters since. 558 funds tracked by Wall St. Rank hold INCY as of Q4 2022.

  • Seeyond held 85,621 shares of Incyte worth $6.88M as of Q4 2022.
  • Seeyond bought 2,441 Incyte shares in Q4 2022, an estimated $187K.
  • Incyte made up 0.67% of Seeyond's portfolio in Q4 2022, its #19 holding.
  • Seeyond first reported a position in Incyte in Q4 2018 and has held it in 17 quarters since.
  • 558 funds tracked by Wall St. Rank held Incyte as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.